NO20013887D0 - Cykliske substituerte sammensmeltede pyrrolokarbazoler og isoindoloner - Google Patents
Cykliske substituerte sammensmeltede pyrrolokarbazoler og isoindolonerInfo
- Publication number
- NO20013887D0 NO20013887D0 NO20013887A NO20013887A NO20013887D0 NO 20013887 D0 NO20013887 D0 NO 20013887D0 NO 20013887 A NO20013887 A NO 20013887A NO 20013887 A NO20013887 A NO 20013887A NO 20013887 D0 NO20013887 D0 NO 20013887D0
- Authority
- NO
- Norway
- Prior art keywords
- isoindolones
- substituted fused
- cyclic substituted
- fused pyrrolocarbazoles
- pyrrolocarbazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11983499P | 1999-02-12 | 1999-02-12 | |
US09/500,849 US6841567B1 (en) | 1999-02-12 | 2000-02-10 | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
PCT/US2000/003476 WO2000047583A1 (en) | 1999-02-12 | 2000-02-11 | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20013887D0 true NO20013887D0 (no) | 2001-08-09 |
NO20013887L NO20013887L (no) | 2001-10-11 |
NO322210B1 NO322210B1 (no) | 2006-08-28 |
Family
ID=26817753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20013887A NO322210B1 (no) | 1999-02-12 | 2001-08-09 | Sykliske substituerte sammensmeltede pyrrolokarbazoler og isoindoloner |
Country Status (18)
Country | Link |
---|---|
US (3) | US6841567B1 (no) |
EP (1) | EP1165562A1 (no) |
JP (1) | JP2003529537A (no) |
KR (1) | KR100697732B1 (no) |
CN (1) | CN1350537A (no) |
AU (1) | AU773335B2 (no) |
BR (1) | BR0008056A (no) |
CA (1) | CA2359772C (no) |
CZ (1) | CZ20012878A3 (no) |
EA (1) | EA005273B1 (no) |
HR (1) | HRP20010583A2 (no) |
IS (1) | IS6015A (no) |
NO (1) | NO322210B1 (no) |
NZ (1) | NZ513097A (no) |
PL (1) | PL352530A1 (no) |
SK (1) | SK11292001A3 (no) |
TR (1) | TR200102338T2 (no) |
WO (1) | WO2000047583A1 (no) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6811992B1 (en) | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
US6841567B1 (en) * | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
US7122679B2 (en) * | 2000-05-09 | 2006-10-17 | Cephalon, Inc. | Multicyclic compounds and the use thereof |
CZ2003680A3 (cs) * | 2000-08-11 | 2003-11-12 | Cephalon, Inc. | Způsob modulace kinasových proteinů s vícenásobnou vazbou a vyhledávání sloučenin modulujících kinasové proteiny s vícenásobnou vazbou |
US6630500B2 (en) | 2000-08-25 | 2003-10-07 | Cephalon, Inc. | Selected fused pyrrolocarbazoles |
US7018999B2 (en) | 2001-05-16 | 2006-03-28 | Cephalon, Inc. | Methods for the treatment and prevention of pain |
DE10164581A1 (de) * | 2001-12-14 | 2003-06-26 | Gruenenthal Gmbh | Substituierte Aminoalkohole |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
KR101201603B1 (ko) | 2003-07-30 | 2012-11-14 | 리겔 파마슈티칼스, 인크. | 자가면역 질환의 치료 또는 예방에 사용하기 위한2,4-피리미딘디아민 화합물 |
US7241779B2 (en) | 2003-12-23 | 2007-07-10 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US7169802B2 (en) | 2003-12-23 | 2007-01-30 | Cephalon, Inc. | Fused pyrrolocarbazoles |
DE102004025726B4 (de) * | 2004-05-26 | 2006-07-06 | Roder, Hanno, Dr. | Verwendung eines spezifischen K252a-Derivats zur Verhinderung oder Behandlung der Alzheimerschen Krankheit |
US20060058250A1 (en) * | 2004-09-10 | 2006-03-16 | Cephalon, Inc. | Methods of treating proliferative skin diseases using carbazole derivatives |
US7491732B2 (en) | 2005-06-08 | 2009-02-17 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the JAK pathway |
US20070203161A1 (en) | 2006-02-24 | 2007-08-30 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
US8962643B2 (en) | 2006-02-24 | 2015-02-24 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the JAK pathway |
US20080021013A1 (en) * | 2006-07-21 | 2008-01-24 | Cephalon, Inc. | JAK inhibitors for treatment of myeloproliferative disorders |
WO2008076394A1 (en) * | 2006-12-14 | 2008-06-26 | Tautatis, Inc. | Compositions and methods for the treatment of cancer |
EP2117544A4 (en) * | 2006-12-19 | 2010-03-03 | Univ Texas | BIOMARKER FOR IDENTIFYING REACTIVATION OF STAT3 AFTER INHIBITION OF SRC |
CA2693694A1 (en) * | 2007-06-08 | 2008-12-11 | University Of Massachusetts | Mixed lineage kinases and metabolic disorders |
CN102007124B (zh) | 2008-02-15 | 2014-06-18 | 里格尔制药公司 | 嘧啶-2-胺化合物及其作为jak激酶抑制剂的用途 |
WO2009111644A2 (en) * | 2008-03-05 | 2009-09-11 | The Regents Of The University Of Michigan | Compositions and methods for diagnosing and treating pancreatic cancer |
US8138339B2 (en) | 2008-04-16 | 2012-03-20 | Portola Pharmaceuticals, Inc. | Inhibitors of protein kinases |
US8063058B2 (en) | 2008-04-16 | 2011-11-22 | Portola Pharmaceuticals, Inc. | Inhibitors of syk and JAK protein kinases |
US8258144B2 (en) | 2008-04-22 | 2012-09-04 | Portola Pharmaceuticals, Inc. | Inhibitors of protein kinases |
NZ592868A (en) | 2008-11-19 | 2012-08-31 | Cephalon Inc | Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound |
EP2459195A1 (en) * | 2009-07-28 | 2012-06-06 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
CN102869775A (zh) | 2009-09-30 | 2013-01-09 | 哈佛大学校长及研究员协会 | 通过调节自噬抑制基因产物调节自噬的方法 |
TW201300360A (zh) | 2010-11-01 | 2013-01-01 | Portola Pharm Inc | 做為jak激酶調節劑之菸鹼醯胺 |
BR112013024169A2 (pt) * | 2011-04-07 | 2016-12-06 | Ariad Pharma Inc | método para o tratamento e prevenção da doença de parkinson |
BR112014012396B1 (pt) | 2011-11-23 | 2020-08-25 | Portola Pharmaceuticals, Inc | inibidores de pirazina quinase, composição, método in vitro para inibição de quinase syk ou via de transdução de sinal, uso dos referidos inibidores e kit |
EP2785184B1 (en) | 2011-11-30 | 2020-06-10 | Emory University | Compositions comprising jak inhibitors and haart drugs for use in the prevention or treatment of hiv |
EP2903970A4 (en) | 2012-10-08 | 2016-11-30 | Portola Pharm Inc | SUBSTITUTED PYRIMIDINYL KINASE INHIBITORS |
EP2968322B1 (en) | 2013-03-15 | 2018-12-26 | The Trustees of Columbia University in the City of New York | Map kinase modulators and uses thereof |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US473939A (en) * | 1892-05-03 | mason | ||
JPS62220196A (ja) | 1986-03-20 | 1987-09-28 | Kyowa Hakko Kogyo Co Ltd | 新規物質ucn―01 |
US4816450A (en) | 1986-09-15 | 1989-03-28 | Duke University | Inhibition of protein kinase C by long-chain bases |
US4735939A (en) | 1987-02-27 | 1988-04-05 | The Dow Chemical Company | Insecticidal activity of staurosporine |
WO1988007045A1 (en) | 1987-03-09 | 1988-09-22 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of physiologically active substance k-252 |
JPH07113027B2 (ja) | 1987-12-24 | 1995-12-06 | 協和醗酵工業株式会社 | K−252誘導体 |
FR2631199B1 (fr) | 1988-05-09 | 1991-03-15 | Centre Nat Rech Scient | Reacteur a plasma |
US5621100A (en) | 1992-07-24 | 1997-04-15 | Cephalon, Inc. | K-252a derivatives for treatment of neurological disorders |
US5621101A (en) | 1992-07-24 | 1997-04-15 | Cephalon, Inc. | Protein kinase inhibitors for treatment of neurological disorders |
US5461146A (en) | 1992-07-24 | 1995-10-24 | Cephalon, Inc. | Selected protein kinase inhibitors for the treatment of neurological disorders |
ES2118414T3 (es) | 1993-05-28 | 1998-09-16 | Cephalon Inc | Utilizacion de derivados del indolocarbazol para el tratamiento de la prostata. |
US5624949A (en) | 1993-12-07 | 1997-04-29 | Eli Lilly And Company | Protein kinase C inhibitors |
US5545636A (en) | 1993-12-23 | 1996-08-13 | Eli Lilly And Company | Protein kinase C inhibitors |
SI0817627T1 (no) | 1993-12-23 | 2005-08-31 | Lilly Co Eli | |
US5475110A (en) | 1994-10-14 | 1995-12-12 | Cephalon, Inc. | Fused Pyrrolocarbazoles |
US5591855A (en) | 1994-10-14 | 1997-01-07 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US5594009A (en) | 1994-10-14 | 1997-01-14 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US5705511A (en) * | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
WO1997007081A2 (en) | 1995-08-11 | 1997-02-27 | Yale University | Glycosylated indolocarbazole synthesis |
WO1997018809A1 (en) | 1995-11-20 | 1997-05-29 | Eli Lilly And Company | Protein kinase c inhibitor |
US5808060A (en) | 1995-12-11 | 1998-09-15 | Cephalon, Inc. | Fused isoindolones |
US5616724A (en) | 1996-02-21 | 1997-04-01 | Cephalon, Inc. | Fused pyrrolo[2,3-c]carbazole-6-ones |
BR9711306A (pt) | 1996-08-22 | 1999-08-17 | Bristol Myers Squibb Co | Amino a-Úcar citotÄxico e derivados de a-Úcar correlatos de indolopirrolocarbazÄis |
DE69911935T3 (de) | 1998-03-13 | 2008-02-07 | The University Of British Columbia, Vancouver | Granulatimide-derivate zur behandlung von krebs |
US6127401A (en) * | 1998-06-05 | 2000-10-03 | Cephalon, Inc. | Bridged indenopyrrolocarbazoles |
HUP0103079A3 (en) | 1998-08-26 | 2004-03-01 | Cephalon Inc | Modulating multiple lineage kinase proteins |
US6841567B1 (en) * | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
-
2000
- 2000-02-10 US US09/500,849 patent/US6841567B1/en not_active Expired - Lifetime
- 2000-02-11 SK SK1129-2001A patent/SK11292001A3/sk unknown
- 2000-02-11 BR BR0008056-0A patent/BR0008056A/pt not_active Application Discontinuation
- 2000-02-11 NZ NZ513097A patent/NZ513097A/en not_active IP Right Cessation
- 2000-02-11 AU AU33604/00A patent/AU773335B2/en not_active Ceased
- 2000-02-11 JP JP2000598503A patent/JP2003529537A/ja active Pending
- 2000-02-11 CA CA002359772A patent/CA2359772C/en not_active Expired - Fee Related
- 2000-02-11 WO PCT/US2000/003476 patent/WO2000047583A1/en active IP Right Grant
- 2000-02-11 TR TR2001/02338T patent/TR200102338T2/xx unknown
- 2000-02-11 CZ CZ20012878A patent/CZ20012878A3/cs unknown
- 2000-02-11 CN CN00803647A patent/CN1350537A/zh active Pending
- 2000-02-11 EP EP00911759A patent/EP1165562A1/en not_active Ceased
- 2000-02-11 KR KR1020017010212A patent/KR100697732B1/ko not_active IP Right Cessation
- 2000-02-11 EA EA200100887A patent/EA005273B1/ru not_active IP Right Cessation
- 2000-02-11 PL PL00352530A patent/PL352530A1/xx not_active Application Discontinuation
-
2001
- 2001-07-20 IS IS6015A patent/IS6015A/is unknown
- 2001-08-07 HR HR20010583A patent/HRP20010583A2/hr not_active Application Discontinuation
- 2001-08-09 NO NO20013887A patent/NO322210B1/no not_active IP Right Cessation
-
2004
- 2004-01-12 US US10/755,505 patent/US7074793B2/en not_active Expired - Fee Related
-
2006
- 2006-02-02 US US11/346,524 patent/US7288650B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU773335B2 (en) | 2004-05-20 |
US6841567B1 (en) | 2005-01-11 |
AU3360400A (en) | 2000-08-29 |
SK11292001A3 (sk) | 2002-04-04 |
EA200100887A1 (ru) | 2002-02-28 |
US7288650B2 (en) | 2007-10-30 |
BR0008056A (pt) | 2002-04-09 |
CZ20012878A3 (cs) | 2002-08-14 |
JP2003529537A (ja) | 2003-10-07 |
NZ513097A (en) | 2004-05-28 |
US20060128780A1 (en) | 2006-06-15 |
US20040186157A1 (en) | 2004-09-23 |
EA005273B1 (ru) | 2004-12-30 |
WO2000047583A1 (en) | 2000-08-17 |
NO20013887L (no) | 2001-10-11 |
HRP20010583A2 (en) | 2002-08-31 |
TR200102338T2 (tr) | 2002-07-22 |
KR20010102085A (ko) | 2001-11-15 |
WO2000047583A8 (en) | 2001-03-29 |
CA2359772A1 (en) | 2000-08-17 |
EP1165562A1 (en) | 2002-01-02 |
WO2000047583A9 (en) | 2001-09-20 |
NO322210B1 (no) | 2006-08-28 |
CA2359772C (en) | 2009-08-11 |
IS6015A (is) | 2001-07-20 |
CN1350537A (zh) | 2002-05-22 |
PL352530A1 (en) | 2003-08-25 |
KR100697732B1 (ko) | 2007-03-22 |
US7074793B2 (en) | 2006-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20013887D0 (no) | Cykliske substituerte sammensmeltede pyrrolokarbazoler og isoindoloner | |
DK1454907T3 (da) | Quninazolin og pyridopyrmidin-derivativer | |
DE50013969D1 (de) | Querverbinder | |
NO2010019I2 (no) | 6-per-deoksy-6-per-(2-karboksetyl)tio-y-cyklodextrin | |
DE69922494D1 (de) | Zyklische n-acylamin-derivate | |
DK1131301T3 (da) | 2-phenylbenzimidazoler og 2-phenylindoler, fremstilling af anvendelse heraf | |
DK1233964T3 (da) | Ny anvendelse og hidtil ukendte N-azabicycloamidderivater | |
DE69836434D1 (de) | Deaktivierbarer schwingkreis | |
NO20021449D0 (no) | Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav | |
DE29805985U1 (de) | Faltbares Gestell | |
DK1261585T3 (da) | Substituerede indol-Mannichbaser | |
ATA111299A (de) | Schnullersauger | |
DE60024400D1 (de) | Empfangsgerät | |
FI990462A (fi) | Resonaattorisuodatin | |
NO20021275D0 (no) | Transgent produserte fusjonsproteiner | |
PT1178981E (pt) | 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos | |
DE29901646U1 (de) | Pfosten | |
FI980268A0 (fi) | Foerfarande foer framstaellning av cykliska monomerer | |
FI991256A (fi) | Apulaite tarjoilua varten | |
NO20013699D0 (no) | Meg-4-protein | |
NO20021244D0 (no) | Subenhet-optimaliserte fusjonsproteiner | |
HU0105363D0 (en) | Cyclic substituted fused pyrrolocarbazoles and isoindolones | |
DE29811850U1 (de) | Gerüst | |
DE29903413U1 (de) | Zahnstocher | |
DK1206473T3 (da) | Isomerfusionerede pyrrolocarbazoler og isoindoloner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |